Request Your Free Playbook Now:

"Mapping a Better Launch Strategy for Cell and Gene Therapies"

This playbook explores what experts say innovators should consider as they advance their pipelines of advanced therapies.

With more assets in development across a growing number of therapeutic areas, the life-changing potential of CGTs is palpable—but they’re not without their complexities and challenges. 

Challenges posed by CGTs reach across the product lifecycle, from developing investigative new drug applications (INDs) to building the network channel strategy, generating an evidence and value story, and supporting patient access.

Is your launch strategy ready to navigate the uncertain road ahead? Inside this playbook, we’ll discuss what’s new—and what experts say CGT innovators should consider as they advance their pipelines of advanced therapies. You’ll learn:

• Key considerations across regulations, RWE, network channel strategy, and market access
• What to look for in a partner when commercializing cell and gene therapies
• How to approach your commercial plan with more confidence

Offered Free by: BioPharma Dive's studioID and Cardinal Health
See All Resources from: BioPharma Dive's studioID and Cardinal Health